A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 4

Paired -tests of primary clinician and self-rated scales from TMS treatment A1 to TMS follow-up A1 across the entire sample.

Measure	Mean		Std. error mean difference	Mean difference			Sig. (2-tailed)
	TxA1	FxA1
PHQ-9	15.42	11.68	1.4118	3.7368	2.647	18	.016
GAD-7	14.00	9.05	1.3796	4.9474	3.586	18	.002
PCL-5	32.68	18.95	4.0967	13.7368	3.353	18	.004
PROMIS pain intensity	4.89	4.42	.2076	.4737	2.282	18	.035
SF-36 emotional well-being	34.32	43.79	4.2187	-9.4737	-2.246	18	.038
MADRS	28.68	20.84	2.7500	7.8421	2.852	18	.011
HAM-A	22.63	16.00	2.0508	6.6316	3.234	18	.005
CAPS-5	26.89	18.68	2.8904	8.2105	2.841	18	.011
PROMIS pain interference	12.47	12.47	.5407	.0000	.000	18	1.000